Lord, Abbett & Co »

Enliven Therapeutics shares owned by Lord, Abbett & Co

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Lord, Abbett & Co from 13F filings

Historical chart of Lord, Abbett & Co investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Lord, Abbett & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Lord, Abbett & Co

Quarter filed Position value Share count Share price at filing
2024-09-30 $8.2M 321k 25.41